Total planned funding: $1,681,130,630
Allocations
Countries/Regions
South Africa | $281,465,831 |
Kenya | $247,044,860 |
Nigeria | $203,020,453 |
Ethiopia | $146,734,666 |
Tanzania | $145,258,630 |
Uganda | $138,742,455 |
Zambia | $135,188,352 |
Mozambique | $81,499,682 |
Rwanda | $64,507,378 |
Côte d'Ivoire | $50,682,284 |
Haiti | $49,449,651 |
Namibia | $41,830,160 |
Botswana | $35,812,487 |
Vietnam | $28,204,287 |
Guyana | $12,262,546 |
Zimbabwe | $7,689,773 |
India | $2,790,652 |
Cambodia | $2,343,835 |
Russia | $1,985,000 |
China | $1,112,650 |
Malawi | $723,835 |
Ghana | $692,067 |
Democratic Republic of the Congo | $459,391 |
Dominican Republic | $450,000 |
Eswatini | $430,000 |
Lesotho | $382,000 |
Thailand | $215,605 |
Indonesia | $137,100 |
South Sudan | $15,000 |
Organizational Types
Unknown | $682,625,796 |
NGO | $280,738,203 |
Private Contractor | $242,157,715 |
University | $220,423,926 |
FBO | $137,246,709 |
Host Country Government Agency | $54,828,892 |
Implementing Agency | $27,433,370 |
Other USG Agency | $17,864,339 |
Own Agency | $10,906,680 |
Multi-lateral Agency | $3,763,000 |
Parastatal | $3,142,000 |
Program Areas
Treatment | $1,681,130,630 |
Budget Codes
HTXS: Treatment: Adult Treatment | $998,846,690 |
HTXD: Treatment: ARV Drugs | $682,283,940 |